Skokie, ILLINOIS2 Active Studies

Lung Cancer Clinical Trials in Skokie, ILLINOIS

Find 2 actively recruiting lung cancer clinical trials in Skokie, ILLINOIS. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
720
Enrolling

Recruiting Lung Cancer Studies in Skokie

About Lung Cancer Clinical Trials in Skokie

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 2 lung cancer clinical trials recruiting participants in Skokie, ILLINOIS. These studies are seeking a combined 720 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Skokie — FAQ

Are there lung cancer clinical trials in Skokie?

Yes, there are 2 lung cancer clinical trials currently recruiting in Skokie, ILLINOIS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Skokie?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Skokie research site will contact you about next steps.

Are clinical trials in Skokie free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Skokie studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 2 active trials in Skokie are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov